Optimer Reviews

2 Reviews
1.0
2 Reviews

Recommend to a friend
Approve of CEO
Optimer President, CEO, and Director S. Pedro Lichtinger
S. Pedro Lichtinger
2 Ratings
  1. 1 person found this helpful  

    Sucks

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Optimer

    Pros

    None to speak of at all

    Cons

    Everything about this company is dirgraceful

    Advice to ManagementAdvice

    Resign in disgrace

    Doesn't Recommend
    Negative Outlook
    Disapproves of CEO

Optimer Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Edit Profile
Website www.optimerpharma.com
Headquarters San Diego, CA
Size 150 to 499 Employees
Founded 1999
Type Company - Public
Industry Biotech & Pharmaceuticals
Revenue $50 to $100 million (USD) per year
Competitors Pfizer, Bayer, Sanofi-Aventis

Optimer Pharmaceuticals has good reason to be optimistic: its lead drug Fidaxomicin kills a wicked and persistent bacteria better than anything else. Presented under the market name Dificid, Fidaxomicin has been approved for treating Clostridium difficile-associated diarrhea, commonly acquired in hospitals. Its Pruvel antibiotic is also in late-stage clinical trials for the treatment of infectious traveler's diarrhea. Through the manipulation of carbohydrates, the company is using its OPopS technology to identify other potential drug candidates for diseases such as breast... More

Worked for Optimer? Contribute to the Community!